Lombard Medical goes for Americexit and possible sale
The public company based in the U.K. has struggled to gain a foothold in the U.S. market and has eliminated its sales force and moved commercial operations to Europe.
The public company based in the U.K. has struggled to gain a foothold in the U.S. market and has eliminated its sales force and moved commercial operations to Europe.
The Altura device offers a way to graft to the renal artery in a less invasive manner that's meant to be simpler and more intuitive.